pharma · AML With Gene Mutations
Lomond Therapeutics Holdings
Lomond Therapeutics Holdings is a pharma organization headquartered in CN. Primary therapeutic focus areas include AML With Gene Mutations. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent reco
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
ZE46-0134
Phase 1 · small molecule · AML With Gene Mutations
ZE46-0134 for AML With Gene Mutations is a Phase 1 program (small_molecule) at Lomond Therapeutics Holdings with 1 ClinicalTrials.gov record(s).
Internal code ZE46-0134-0002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Lomond Therapeutics Holdings
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- AML With Gene Mutations
- Status
- active
- Trials
- 1